Table 2 tDCS protocols
Study | Treatment | Session # | Active tDCS | Stimulation Site | Stimulation Parameters (Intensity, Duration, Areas) | Follow-Up Test |
|---|---|---|---|---|---|---|
Alizad [42] | tDCS | 3 | A | M: Bi PMC & M1 | 1 mA, 20 min, 40 cm2 | No |
Benninger [43] | tDCS | 8 | A | M: Bi PFC, PMC, & M1 (separately) | 2 mA, 20 min, 24.5 cm2 | Yes (12wks) |
Capacci [44] | tDCS | 1 | A | M: Bi PFC (separately) | 2 mA, 20 min, NA | No |
Costa-Ribeiro [45] | tDCS> | 10 | A | S: Central leg areas M1 (2 cm anterior to the vertex) | 2 mA, 13 min, NA | Yes (4wks) |
Costa-Ribeiro [46] | tDCS> | 10 | A | S: Central leg areas M1 (2 cm anterior to the vertex) | 2 mA, 13 min, 35 cm2 | Yes (4wks) |
Criminger [47] | tDCS | 3 | A&C | M: Bi DLPFC (A-tDCS on LH & C-tDCS on RH) | 2 mA, 20 min, 15 cm2 | No |
da Silva [48] | tDCS | 1 | A | S: Central leg areas M1 & SMA | 2 mA, 15 min, 35 cm2 | No |
Dagan [49] | tDCS | 2 | A | M: M1 & LH-DLPFC | 20 min, NA, NA | No |
Fernández-Lago [50] | tDCS&TT | 1 | A | S: leg area M1 of AH | 2 mA, 20 min, 3.5 cm2 | No |
Kaski [51] | tDCS&PT | 1 | A | S: Central leg areas M1 (10–20% anterior to the vertex) | 2 mA, 15 min, 40 cm2 | No |
Lattari [52] | tDCS | 1 | A | S: LH DLPFC | 2 mA, 20 min, 35 cm2 | No |
Mak [53] | tDCS | 5 | A | S: M1 | NA, 20 min, NA | No |
Manenti [54] | tDCS | 2 | A | S: RH DLPFC | 2 mA, 7 min, 35 cm2 | No |
Schabrun [55] | tDCS> | 9 | A | S: LH M1 | 2 mA, 20 min, 35 cm2 | Yes (12wks) |
Swank [56] | tDCS | 1 | A&C | M: Bi DLPFC (A-tDCS on LH & C-tDCS on RH) | 2 mA, 20 min, NA | No |
Valentino [57] | tDCS | 5 | A | S: Central leg areas M1 | 2 mA, 20 min, NA | Yes (4wks) |
Verheyden [58] | tDCS | 1 | A | S: LH M1 | 1 mA, 15 min, NA | No |
Yotnuengnit [59] | tDCS&PT | 6 | A | S: Central leg areas M1 | 2 mA, 30 min, 35 cm2 | Yes (8wks) |